Trevor Bushell

Dr. Trevor Bushell is a Reader at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, where he has been a faculty member since 2002. He is affiliated with the Faculty of Science and leads the Neuroscience and Mental Health research group. He holds a BSc (Hons) in Pharmacology from the University of Glasgow (1992) and a PhD in Neuroscience from the University of Bristol (1996), with postdoctoral experience at the University of Chicago and Imperial College London.

His research centers on the modulation of neuronal excitability and synaptic transmission in both healthy and diseased states. Key areas include the role of protease-activated receptor 2 (PAR-2), Toll-like receptor 3 (TLR3), and mitogen-activated protein kinase phosphatase-2 (MKP2) in the central nervous system, as well as the impact of peripheral inflammation on CNS function and behavior. He also develops novel microfluidic devices for neuroscience applications in collaboration with Dr. Michele Zagnoni.

His recent publications reflect a multidisciplinary approach combining electrophysiology, molecular biology, immunocytochemistry, and advanced imaging techniques. Themes include neuroprotection, neuroinflammation, and high-resolution microscopy, often in collaboration with Professor Judy Pratt on rodent behavioral models. His work contributes to understanding neurodegenerative conditions such as Alzheimer's disease and multiple sclerosis.

• Best poster prize at ARUK 2025 conference

Dr. Bushell is actively involved in teaching MPharm and Biomedical Science (BMS) students across all years. He supervises multiple research projects as Principal or Co-Investigator, including studies on depression-like behavior in Alzheimer’s models and cerebral organoids for stroke modeling. He is the Strathclyde representative for the British Neuroscience Association, a member of the Society for Neuroscience, and a Fellow of the Higher Education Academy. His lab utilizes mammalian expression systems, cultured neurons, brain slices, and behavioral assays to investigate CNS pathophysiology.